Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04094311
Title Study of Out of Specification for Tisagenlecleucel
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

B-cell lymphoma

B-cell acute lymphoblastic leukemia

diffuse large B-cell lymphoma

Therapies

Tisagenlecleucel

Age Groups: adult | senior | child
Covered Countries CAN


No variant requirements are available.